Human EGFR (Epidermal Growth Factor Receptor) - Recombinant Protein
Beta LifeScience
            SKU/CAT #: BLT-04223P
          
      
 
    SDS-PAGE analysis of Human EGFR (Epidermal Growth Factor Receptor) - Recombinant Protein, CAT# BLT-04223P, showing >95% purity under 15% SDS-PAGE (Reduced)
  
Human EGFR (Epidermal Growth Factor Receptor) - Recombinant Protein
Beta LifeScience
            SKU/CAT #: BLT-04223P
          
            
                      
                            Regular price
                        
                        
                          $59500
  $595.00
                        
                        Sale price$54500
  $545.00Save $50
/
                      
                    Quantity Pricing
| Pack Size | Price (USD) | 
|---|---|
| 500 µg | $1,375 | 
| 1 mg | $2,245 | 
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Epidermal Growth Factor Receptor (EGFR) Protein | 
| Product Overview | This recombinant human Epidermal Growth Factor Receptor (EGFR) protein includes amino acids 25-30aa&298-645aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. | 
| Target Uniprot Id | P00533 | 
| Recommended Name | Epidermal growth factor receptor | 
| Gene Name | EGFR | 
| Synonyms | Epidermal growth factor receptor; EGFR; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase er | 
| Species | Human | 
| Predicted Molecular Mass | 65.8 kDa | 
| Expression System | Mammalian Cell | 
| Expression Range | 25-30aa&298-645aa | 
| Tag | C-Fc | 
| Purity | >95% | 
| Formulation | Lyophilized | 
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose | 
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. | 
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. | 
| Applications | Positive Control; Immunogen; SDS-PAGE; WB | 
| Research Area | Cancer | 
| Target Function | Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Positively regulates cell migration via interaction with CCDC88A/GIV which retains EGFR at the cell membrane following ligand stimulation, promoting EGFR signaling which triggers cell migration. Plays a role in enhancing learning and memory performance.; Isoform 2 may act as an antagonist of EGF action.; (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. | 
| Subcellular Location | Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Nucleus membrane; Single-pass type I membrane protein. Endosome. Endosome membrane. Nucleus.; [Isoform 2]: Secreted. | 
| Protein Family | Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily | 
| Associated Diseases | Lung cancer (LNCR); Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) | 
| Tissue Specificity | Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers. | 
        
      
          
        